Stereotaxis Reports 2021 First Quarter Financial Results
May 10, 2021 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 10, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis to Report First Quarter 2021 Financial Results on May 10, 2021
April 19, 2021 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 19, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
Stereotaxis CEO Invited as Keynote Speaker at Robotic Surgery & Enabling Technologies Summit 2021
April 12, 2021 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 12, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that David Fischel,...
Broward Health Medical Center Becomes First Hospital in Florida to Adopt Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders
April 07, 2021 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 07, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that Broward Health...
Stereotaxis to Establish Global Headquarters in Downtown St. Louis Globe Building
March 08, 2021 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 08, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced it will move...
Stereotaxis Reports 2020 Full Year Financial Results
February 25, 2021 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis Announces Long-Term CEO Performance Stock Award
February 24, 2021 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a 10-year CEO...
Stereotaxis to Present at Upcoming Investor Conferences
February 11, 2021 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Stereotaxis to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
February 04, 2021 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
Stereotaxis Reports 2020 Third Quarter Financial Results
November 09, 2020 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...